A new clinical trial has stirred fresh debate about tools to quit smoking, reporting that psilocybin-assisted therapy may outperform nicotine replacement products. The study’s results, if replicated, could reshape how clinicians approach tobacco dependence and push psychedelic-assisted treatments into mainstream addiction care. Major finding: psilocybin outperforms nicotine patch Researchers report …